Novolog
Product Images NDC 68258-8899

Product Visual Gallery

This gallery contains 31 technical images submitted to the FDA as part of the official labeling for Novolog (NDC 68258-8899). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig. 1 (Structural Formula of Insulin Aspart)

FDA Label Image

Fig. 2 (Pharmacodynamics Graph showing Maximum Glucose-Lowering Effect of NovoLog)

FDA Label Image

Fig. 3 (Pharmacodynamics Graph)

This text appears to be a chart or table displaying blood glucose levels in mg/dL at various time intervals, with some additional notes about the time axis. However, the last line of seemingly random characters is unclear and does not provide additional context.*

FDA Label Image

Fig. 4 (Pharmacokinetics Graph showing Bioavailability and Absorption of NovoLog)

FDA Label Image

Vial Figure (70e689b2 1ad1 4632 B851 B38b7ee6e14f 05)

FDA Label Image

Hand And Vial Figure (70e689b2 1ad1 4632 B851 B38b7ee6e14f 06)

FDA Label Image

Figure A And Figure B (70e689b2 1ad1 4632 B851 B38b7ee6e14f 07)

FDA Label Image

Figure C (70e689b2 1ad1 4632 B851 B38b7ee6e14f 08)

FDA Label Image

Figure D (70e689b2 1ad1 4632 B851 B38b7ee6e14f 09)

FDA Label Image

Figure E (70e689b2 1ad1 4632 B851 B38b7ee6e14f 10)

FDA Label Image

Figure F (70e689b2 1ad1 4632 B851 B38b7ee6e14f 11)

FDA Label Image

Figure G (70e689b2 1ad1 4632 B851 B38b7ee6e14f 12)

FDA Label Image

Figure H (70e689b2 1ad1 4632 B851 B38b7ee6e14f 13)

FDA Label Image

Figure I (70e689b2 1ad1 4632 B851 B38b7ee6e14f 14)

FDA Label Image

Figure J (70e689b2 1ad1 4632 B851 B38b7ee6e14f 15)

FDA Label Image

Figure K (70e689b2 1ad1 4632 B851 B38b7ee6e14f 16)

FDA Label Image

Figure L (70e689b2 1ad1 4632 B851 B38b7ee6e14f 17)

FDA Label Image

Instructions For Use (NovoLog FlexPen)

FDA Label Image

A (Preparing the NovoLog FlexPen)

FDA Label Image

B (Attaching the Needle)

FDA Label Image

C (Pulling off the big outer needle cap)

FDA Label Image

D (Pulling off the inner needle cap)

FDA Label Image

E (Giving the airshot before each injection- Turn the dose selector to select 2 units)

FDA Label Image

F (Giving the airshot before each injection)

FDA Label Image

G (Giving the airshot before each injection)

FDA Label Image

H (Selecting the dose)

FDA Label Image

I (Giving the injection)

FDA Label Image

J (Giving the injection)

FDA Label Image

K (After the injection)

FDA Label Image

L (Function Check)

FDA Label Image

Ndc 68258-8899-03 (Ndc 68258 8899 03 Novo)

The text is a description of a diabetes medication, the Novolog Flexpen 100 units/mL (U-100), manufactured by Novo Nordisk A/S in Denmark. The medication is supplied in a prefilled insulin syringe, accompanied by instructions and warnings. The drug should be kept in a dark place, below 86°F, and not frozen. The packaging includes information such as the lot number, product ID, and expiration date. Children should not have access to the medication. The medication is stored at Dispensing & Solutions in Santa Ana, CA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.